Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DW4421 Multiple Ascending Dose Study in Healthy Volunteers
NCT07691242Phase 1Not yet recruiting
- Sponsor
- Daewon Pharm
- Start
- Sep 2026
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 1 trial of DW4421-1 (7 cohorts), sponsored by Daewon Pharm. Primary endpoints: Area under the drug concentration-time curve at steady state at 7 days and Maximum observed drug concentration at 7 days. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
DW4421-1
Beyond the preview
Go deeper on NCT07691242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07691242.